Nan Fung Group Holdings’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Nan Fung Group Holdings’s Portfolio SRRA Stock Details SRRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-52,979	Closed	-$1.7M	–	48
2022 Q1	$1.7M	Hold	52,979	–	–	0.81%	16
2021 Q4	$1.15M	Hold	52,979	–	–	0.34%	25
2021 Q3	$1.16M	Sell	52,979 -78,000	-60%	-$1.56M	0.37%	21
2021 Q2	$2.55M	Buy	+130,979	New	+$2.38M	0.79%	12

Other funds holding SRRA

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Nan Fung Group Holdings's SRRA Position: Q2 2022 in Review

Nan Fung Group Holdings sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q2 2022, closing a stake of 52,979 shares — an estimated $1.7M sold.

Nan Fung Group Holdings first reported a position in SRRA in Q2 2021 and held it in 4 quarters. The position peaked at $2.55M in Q2 2021. 109 funds tracked by Wall St. Rank hold SRRA as of Q2 2022.

Nan Fung Group Holdings reported no remaining Sierra Oncology, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Nan Fung Group Holdings sold 52,979 Sierra Oncology, Inc. Common Stock shares in Q2 2022, an estimated $1.7M.
Nan Fung Group Holdings first reported a position in Sierra Oncology, Inc. Common Stock in Q2 2021 and held it in 4 quarters.
Nan Fung Group Holdings's Sierra Oncology, Inc. Common Stock position peaked at $2.55M in Q2 2021.
109 funds tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q2 2022.

Based on Nan Fung Group Holdings's 13F filing for Q2 2022, filed 12 Aug 2022.